Showing results (11-20 of 179) with videos related to
Sort By:
Pageof 18
Clinical Oncology, Case Reports|March 25, 2021
Mycophenolate as Primary Treatment for Immune Checkpoint Inhibitor Induced Acute Kidney Injury in a Patient with Concurrent Immunotherapy-Associated Diabetes: A Case ReportShlomit Jessel, Mathew Austin, Harriet M KlugerMedical Oncology (Northwood, London, England)|December 29, 2012
FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicityKrishna S Gunturu, Xiaopan Yao, Xiangyu Cong, et al.BMC Bioinformatics|May 4, 2006
Characterizing disease states from topological properties of transcriptional regulatory networksDavid P Tuck, Harriet M Kluger, Yuval KlugerMethods in Molecular Biology (Clifton, N.J.)|January 8, 2008
Assessing expression of apoptotic markers using large cohort tissue microarraysElah Pick, Mary M McCarthy, Harriet M KlugerCurrent Oncology Reports|August 1, 2016
Evolving Immunotherapy Approaches for Renal Cell CarcinomaSusanna A Curtis, Justine V Cohen, Harriet M KlugerClinics in Dermatology|November 3, 2009
Chemotherapy and biologic therapies for melanoma: do they work?Lucia B Jilaveanu, Saadia A Aziz, Harriet M KlugerCurrent Cancer Drug Targets|December 11, 2012
Studies of NVP-BEZ235 in melanomaJoshua A Sznol, Lucia B Jilaveanu, Harriet M KlugerClinical Oncology, Case Reports|August 12, 2021
Prolonged Complete Response of Early Stage Primary Adenocarcinoma of the Lung to Nivolumab MonotherapySerhan Unlu, Michael J Grant, Scott Gettinger, et al.Clinics in Dermatology|April 24, 2013
Advances in therapy for melanoma brain metastasesJaclyn C Flanigan, Lucia B Jilaveanu, Veronica L Chiang, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 25, 2017
Sarcoidosis Following Anti-PD-1 and Anti-CTLA-4 Therapy for Metastatic MelanomaSwathi B Reddy, Jennifer D Possick, Harriet M Kluger, et al.Pageof 18